Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsPayablesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nexalin Technology (NXL) Cash & Equivalents (2021 - 2025)

Nexalin Technology (NXL) has 5 years of Cash & Equivalents data on record, last reported at $590075.0 in Q3 2025.

  • For Q3 2025, Cash & Equivalents fell 86.92% year-over-year to $590075.0; the TTM value through Sep 2025 reached $590075.0, down 86.92%, while the annual FY2024 figure was $574485.0, 75.74% down from the prior year.
  • Cash & Equivalents reached $590075.0 in Q3 2025 per NXL's latest filing, down from $5.4 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $7.9 million in Q3 2022 and bottomed at $162743.0 in Q4 2022.
  • Average Cash & Equivalents over 5 years is $2.2 million, with a median of $755287.0 recorded in 2021.
  • The widest YoY moves for Cash & Equivalents: up 1355.18% in 2023, down 95.4% in 2023.
  • A 5-year view of Cash & Equivalents shows it stood at $661778.0 in 2021, then tumbled by 75.41% to $162743.0 in 2022, then soared by 1355.18% to $2.4 million in 2023, then tumbled by 75.74% to $574485.0 in 2024, then grew by 2.71% to $590075.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Cash & Equivalents were $590075.0 in Q3 2025, $5.4 million in Q2 2025, and $1.4 million in Q1 2025.